These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 3293832)
21. Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis. Melnick RL; Kohn MC; Portier CJ Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):123-34. PubMed ID: 8722116 [TBL] [Abstract][Full Text] [Related]
22. Fundamental carcinogenic processes and their implications for low dose risk assessment. Crump KS; Hoel DG; Langley CH; Peto R Cancer Res; 1976 Sep; 36(9 pt.1):2973-9. PubMed ID: 975067 [TBL] [Abstract][Full Text] [Related]
23. Cell proliferation not associated with carcinogenesis in rodents and humans. Ward JM; Uno H; Kurata Y; Weghorst CM; Jang JJ Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):125-35. PubMed ID: 8013399 [TBL] [Abstract][Full Text] [Related]
24. Multistage models of carcinogenesis. Armitage P Environ Health Perspect; 1985 Nov; 63():195-201. PubMed ID: 3908088 [TBL] [Abstract][Full Text] [Related]
25. Effect of promoters on incidence of bladder cancer in experimental animal models. Hicks RM Environ Health Perspect; 1983 Apr; 50():37-49. PubMed ID: 6873029 [TBL] [Abstract][Full Text] [Related]
26. Incorporating additional biological phenomena into two-stage cancer models. Sielken RL; Bretzlaff RS; Stevenson DE Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250 [TBL] [Abstract][Full Text] [Related]
27. Chemical mixtures and interactive carcinogenesis: in vitro studies. Williams GM IARC Sci Publ; 1990; (104):107-12. PubMed ID: 2228107 [TBL] [Abstract][Full Text] [Related]
28. [Progression of tumors: etiologic, morphologic and molecular-biological aspects]. Turosov VS Arkh Patol; 1992; 54(7):5-14. PubMed ID: 1471943 [TBL] [Abstract][Full Text] [Related]
29. Initiation-promotion model for assessment of carcinogenicity: medium-term liver bioassay in rats for rapid detection of carcinogenic agents. Imaida K; Fukushima S J Toxicol Sci; 1996 Dec; 21(5):483-7. PubMed ID: 9035059 [TBL] [Abstract][Full Text] [Related]
30. The current use of studies on promoters and cocarcinogens in quantitative risk assessment. Stara JF; Mukerjee D; McGaughy R; Durkin P; Dourson ML Environ Health Perspect; 1983 Apr; 50():359-68. PubMed ID: 6873028 [TBL] [Abstract][Full Text] [Related]
31. Current status of experimental chemical carcinogenesis and its applications to human cancer risk. Lijinsky W Cancer Res; 1979 Jul; 39(7 Pt 2):2887-90. PubMed ID: 376127 [TBL] [Abstract][Full Text] [Related]
32. Risk extrapolation for chlorinated methanes as promoters vs initiators of multistage carcinogenesis. Bogen KT Fundam Appl Toxicol; 1990 Oct; 15(3):536-57. PubMed ID: 2258018 [TBL] [Abstract][Full Text] [Related]
33. Facts and theories concerning the mechanisms of carcinogenesis. Pitot HC; Dragan YP FASEB J; 1991 Jun; 5(9):2280-6. PubMed ID: 1860619 [TBL] [Abstract][Full Text] [Related]
34. The Multiple Chemicals and Actions Model of carcinogenesis. A possible new approach to developing prevention strategies for environmental carcinogenesis. Battershill JM Hum Exp Toxicol; 2005 Nov; 24(11):547-58. PubMed ID: 16323570 [TBL] [Abstract][Full Text] [Related]
35. Quantitative risk assessment and the limitations of the linearized multistage model. Lovell DP; Thomas G Hum Exp Toxicol; 1996 Feb; 15(2):87-104. PubMed ID: 8645508 [TBL] [Abstract][Full Text] [Related]